Xencor | XNCR - Current Liabilities



Xencor reported $96.08M in Current Liabilities for its fiscal quarter ending in June of 2025.


Current Liabilities Change Date
AbbVie USD 36.4B 2.35B Mar/2025
Alnylam Pharmaceuticals USD 1.3B 225.22M Jun/2025
Amgen USD 20.48B 2.53B Jun/2025
Arrowhead Research USD 194.53M 26.01M Jun/2025
AstraZeneca USD 33.54B 4.41B Jun/2025
Biogen USD 3.18B 2.11B Jun/2025
Bristol-Myers Squibb USD 27.53B 3.46B Jun/2025
Cytokinetics USD 131.06M 28.66M Jun/2025
GlaxoSmithKline GBP 20.38B 453M Jun/2025
J&J USD 56.9B 6.58B Mar/2025
MacroGenics USD 39M 16.53M Jun/2025
Merck USD 26.04B 863M Jun/2025
Novartis USD 31.71B 95M Jun/2025
Pfizer USD 37.73B 1.27B Jun/2025
Regeneron Pharmaceuticals USD 3.67B 100.4M Jun/2025
Roche Holding CHF 27.02B 424M Dec/2024
Xencor USD 96.08M 7.65M Jun/2025